03 Jan '23 at 6:08 pm #50667
Keymaster
Wrecked: Phathom Pharmaceuticals $PHAT down 24.9%
FDA notified the company that no action will be taken on its NDA for vonoprazan;
Meaning Phathom no longer expects product launches for H. pylori or erosive esophagitis in 1Q23.